CD4 and cancer: We observed that activated CD4+ T lymphocytes in the presence of a high metformin concentration exhibited a proliferation impairment, resulting in reduced cell counts; thus, we evaluated whether this effect was associated with the capacity of metformin to affect cell cycles, as previously shown in cancer cells [23,24].